On Nov. 3rd, the California Department of Health Care Services (DHCS) announced Pear Therapeutics, Inc. will be the incentive manager vendor for the California Advancing and Innovating Medi-Cal (CalAIM) contingency management benefit, or the Recovery Incentives Program.     Through the program, eligible Medi-Cal beneficiaries struggling with stimulant use will participate in a structured 24-week … Read more